SuperworthMatinas BioPharma shares outstanding MTNB
Diluted shares outstanding, averaged over each quarter, from 2013.
- Latest quarter, to Jun 30, 2026
- 427.1K
- On a year earlier
- +25.9%
- more shares
Matinas BioPharma had 427.1K diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 25.9% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 418.3K | +23% |
| FY2024 | 339.1K | +17% |
| FY2023 | 289.7K | +0% |
| FY2022 | 289.2K | +0% |
| FY2021 | 288.3K | +8% |
| FY2020 | 265.8K | +22% |
| FY2019 | 217.1K | +48% |
| FY2018 | 146.6K | +18% |
| FY2017 | 124.6K | +61% |
| FY2016 | 77.5K | +2% |
| FY2015 | 76.2K | +77% |
| FY2014 | 43K | +3% |
| FY2013 | 41.6K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 427.1K | +26% | |
| Q1 FY26 | 427.1K | +26% | |
| Q4 FY25 | 418.3K | +23% | |
| Q3 FY25 | 362.4K | +8% | |
| Q2 FY25 | 339.1K | +2% | |
| Q1 FY25 | 339.1K | +17% | |
| Q4 FY24 | 339.1K | +17% | |
| Q3 FY24 | 335.9K | +16% | |
| Q2 FY24 | 332.5K | +15% | |
| Q1 FY24 | 289.8K | +0% | |
| Q4 FY23 | 289.7K | +0% | |
| Q3 FY23 | 289.7K | +0% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Matinas BioPharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.